Bota, D. A., Eroglu, Z., Reardon, D. A., Fu, B. D., Norfleet, J., Desjardins, A., … Vredenburgh, J. J. (2011). Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY, 29(15).

Bota, D. A., Z. Eroglu, D. A. Reardon, B. D. Fu, J. Norfleet, A. Desjardins, M. E. Linskey, K. Peters, H. S. Friedman, and J. J. Vredenburgh. “Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.” JOURNAL OF CLINICAL ONCOLOGY 29, no. 15 (May 20, 2011).

Bota DA, Eroglu Z, Reardon DA, Fu BD, Norfleet J, Desjardins A, et al. Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. 2011 May 20;29(15).

Bota, D. A., et al. “Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 29, no. 15, AMER SOC CLINICAL ONCOLOGY, May 2011.

Bota DA, Eroglu Z, Reardon DA, Fu BD, Norfleet J, Desjardins A, Linskey ME, Peters K, Friedman HS, Vredenburgh JJ. Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2011 May 20;29(15).